FEDERATED HERMES, INC. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2020. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2022$189
-81.1%
1320.0%0.00%
Q3 2022$1,0000.0%1320.0%0.00%
Q2 2022$1,0000.0%132
-41.6%
0.00%
Q1 2022$1,0000.0%2260.0%0.00%
Q4 2021$1,0000.0%2260.0%0.00%
Q3 2021$1,0000.0%2260.0%0.00%
Q2 2021$1,0000.0%2260.0%0.00%
Q1 2021$1,0000.0%226
-3.4%
0.00%
Q4 2020$1,0000.0%234
-15.2%
0.00%
Q3 2020$1,0000.0%276
-2.1%
0.00%
Q2 2020$1,0000.0%282
-5.1%
0.00%
Q1 2020$1,0000.0%2970.0%0.00%
Q4 2019$1,0000.0%2970.0%0.00%
Q3 2019$1,0000.0%2970.0%0.00%
Q2 2019$1,0000.0%297
-2.6%
0.00%
Q1 2019$1,0000.0%3050.0%0.00%
Q4 2018$1,000
-75.0%
305
-71.4%
0.00%
Q3 2018$4,000
-55.6%
1,067
-36.1%
0.00%
Q2 2018$9,000
-90.2%
1,669
-90.1%
0.00%
Q1 2018$92,000
-92.9%
16,825
-89.4%
0.00%
-100.0%
Q4 2017$1,288,000
-22.0%
158,080
+0.3%
0.00%
-20.0%
Q3 2017$1,651,000
+25.6%
157,654
+32.5%
0.01%
+25.0%
Q2 2017$1,314,000
+43.8%
119,006
+8.9%
0.00%
+33.3%
Q1 2017$914,000
+9040.0%
109,244
+7465.4%
0.00%
Q4 2016$10,0000.0%1,444
-23.6%
0.00%
Q3 2016$10,0000.0%1,891
+16.4%
0.00%
Q2 2016$10,000
+233.3%
1,624
+120.4%
0.00%
Q1 2016$3,0000.0%7370.0%0.00%
Q4 2015$3,000
+200.0%
737
+98.1%
0.00%
Q3 2015$1,000
-50.0%
372
-38.3%
0.00%
Q2 2015$2,0000.0%6030.0%0.00%
Q1 2015$2,000
-71.4%
603
-55.6%
0.00%
Q3 2014$7,000
-12.5%
1,359
-10.4%
0.00%
Q2 2014$8,0001,5160.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders